Cibus announces important update to rice gene editing conversion rates

Cibus, Inc. (Nasdaq: CBUS) (the ″Company″ or ″Cibus″), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, issued a correction relating to the rice conversion rates previously disclosed in its January 16, 2025 press release. The Company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based upon subsequent experiments and high variability in the conversion rate data. Cibus is continuing to advance its oligonucleotide directed mutagenesis (ODM) editing technologies to drive improved editing conversion rates across its developed traits across its crops of interest.

″Notwithstanding the variability experiment to experiment, we continue to believe that Cibus’ standardized high throughput, semi-automated, Rapid Trait Development System™ (RTDS^®) will deliver what our customers require, which is edits in their germplasm for traits with our time-bound and predictable process,″ stated Greg Gocal, Chief Scientific Officer. ″We remain excited by our technological and process advances to date and look forward to reporting on our future achievements.″